Imperial Innovations

We are a technology commercialisation company, combining the activities of technology transfer, intellectual property licensing and protection, company incubation and investment. We are focused on the commercialisation of the most promising opportunities from a broad range of technology sectors, with particular expertise in therapeutics, medtech, engineering & materials and ICT.

About us Our people Investor relations

£198.3m

invested in UK innovation

During the six months ended 31 January 2015 we invested £22.4 million in our portfolio.

£346.0m

Raised by Innovations

to support investment in and development of our portfolio of technology businesses.

£1 billion

invested in UK innovation

Alongside co-investors, £1 billion has been committed to our portfolio companies since 2006

£1.4 billion

Research Funding

received each year by the universities we focus on (Imperial, Oxford, Cambridge, UCL)

£22.4m

Invested

During the six months ended 31 January 2015 we invested £22.4 million in our portfolio.

35

Accelerated Growth Companies

The focus of our time and capital

Technology Transfer

Technology Transfer

Our Technology Transfer team works with Imperial College London academics and students.

We manage the translation of an idea into practice, working with academic inventors throughout the process of commercialisation, leading ultimately to licensing to industry partners, or the creation of new ventures.

Find out more
Ventures

Ventures

Our ventures team creates, nurtures and invests in new technology ventures based on IP

We work to develop new company opportunities based on leading UK academic research, working with Imperial College London (& our own Technology Transfer team), The Universities of Oxford & Cambridge and UCL.

Find out more

Portfolio overview

We have identified four particular areas of expertise, shown in the diagram below. As at 31 January 2015, the value of the top 20 investments in our portfolio stood at £241.3 million.

Portfolio subsectors
  • Therapeutics
  • Medtech
  • Engineering/Materials
  • ICT/Digital
More about our leading investments
Diagram
Circassia
Sector Investment amount Investment stage
Therapeutics £25.5m Listed
Overview

A clinical-stage specialty biopharmaceutical company developing a range of novel immunotherapies

Orthonika
Sector Investment amount Investment stage
Medtech Seed
Overview

Complete replacement for knee meniscus

Concirrus
Sector Investment amount Investment stage
ICT/Digital £3.0m Series A
Overview

Internet of Things solutions provider specialising in fully integrated business solutions around connected product intelligence.

Investment details

Share price: 482.50p
Diagram
Key information

Sector: Financial Services
Activities: Technology commercialisation, incubation and investment
EPIC: IVO
Status: AIM
Year end: 31 July